​

Funding Round

Convertible Note - SFA Therapeutics

Convertible Note - SFA Therapeutics

Investment Firm

Overview

SFA Therapeutics is a developer of drugs to treat chronic inflammatory diseases.

Announced Date

Nov 09, 2023

Funding Type

Convertible Note

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

North South Ventures

North South Ventures

North South Ventures is a early_stage_venture firm.

Participant Investors

4

Investor Name
Participant InvestorSavantus Ventures
Participant InvestorAsymmetry Ventures
Participant InvestorNorth South Ventures
Participant InvestorBen Franklin Technology Partners of Southeastern Pennsylvania

Round Details and Background

SFA Therapeutics raised $4500000 on 2023-11-09 in Convertible Note

SFA Therapeutics is a developer of drugs to treat chronic inflammatory diseases.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 18, 2020
Grant - SFA Therapeutics
1-100.0K
Jun 20, 2022
Seed Round - SFA Therapeutics
10-4.0M
Aug 17, 2021
Seed Round - SFA Therapeutics
1-125.0K
Nov 09, 2023
Convertible Note - SFA Therapeutics
4-4.5M

Recent Activity

There is no recent news or activity for this profile.